Relutrigine

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C15H11F6N5O2
Molecular Weight	407.2706
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of Relutrigine

Structure Search

SMILES

CCOC(F)(F)C1=NN=C2C=NC(=CN12)C3=CN=C(OCC(F)(F)F)C(F)=C3

InChI

InChIKey=BFXBSYMVTNEFRF-UHFFFAOYSA-N

InChI=1S/C15H11F6N5O2/c1-2-28-15(20,21)13-25-24-11-5-22-10(6-26(11)13)8-3-9(16)12(23-4-8)27-7-14(17,18)19/h3-6H,2,7H2,1H3

HIDE SMILES / InChI

Molecular Formula	C15H11F6N5O2
Molecular Weight	407.2706
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 12:58:53 GMT 2025` Edited by `admin` on `Wed Apr 02 12:58:53 GMT 2025`
Record UNII	AW5C5XHM4W
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

relutrigine [INN]

Preferred Name

English

Relutrigine

Official Name

English

1,2,4-TRIAZOLO(4,3-A)PYRAZINE, 3-(ETHOXYDIFLUOROMETHYL)-6-(5-FLUORO-6-(2,2,2-TRIFLUOROETHOXY)-3-PYRIDINYL)-

Systematic Name

English

3-(ethoxydifluoromethyl)-6-[5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3- yl][1,2,4]triazolo[4,3-a]pyrazine

Systematic Name

English

3-(ethoxydifluoromethyl)-6-[5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3- yl][1,2,4]triazolo[4,3-a]pyrazine

Systematic Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

789620

Created by admin on Wed Apr 02 12:58:53 GMT 2025 , Edited by admin on Wed Apr 02 12:58:53 GMT 2025

FDA ORPHAN DRUG

789420

Created by admin on Wed Apr 02 12:58:53 GMT 2025 , Edited by admin on Wed Apr 02 12:58:53 GMT 2025

Code System Code Type Description

SMS_ID

300000035039

Created by admin on Wed Apr 02 12:58:53 GMT 2025 , Edited by admin on Wed Apr 02 12:58:53 GMT 2025

PRIMARY

INN

12609

Created by admin on Wed Apr 02 12:58:53 GMT 2025 , Edited by admin on Wed Apr 02 12:58:53 GMT 2025

PRIMARY

CAS

2392951-29-8

Created by admin on Wed Apr 02 12:58:53 GMT 2025 , Edited by admin on Wed Apr 02 12:58:53 GMT 2025

PRIMARY

NCI_THESAURUS

C199101

Created by admin on Wed Apr 02 12:58:53 GMT 2025 , Edited by admin on Wed Apr 02 12:58:53 GMT 2025

PRIMARY

PUBCHEM

147075611

Created by admin on Wed Apr 02 12:58:53 GMT 2025 , Edited by admin on Wed Apr 02 12:58:53 GMT 2025

PRIMARY

FDA UNII

AW5C5XHM4W

Created by admin on Wed Apr 02 12:58:53 GMT 2025 , Edited by admin on Wed Apr 02 12:58:53 GMT 2025

PRIMARY

Related Record Type Details


					AW5C5XHM4W

ACTIVE MOIETY

Comments:

PRAX-562 was tested in a range of in vitro, ex vivo, and in vivo nonclinical pharmacology assays to characterize its inhibition of a variety of NaV channels from human and relevant animal species

Amount: